IDH1 and astrocytoma (excluding glioblastoma): Improved PFS was also noted in patients with7pgain and10qloss (p = 0.009), while hypermethylated status and IDHwt astrocytomas as compared with IDH-mutant oligodendrogliomas and diffuse astrocytomas correlated with shorter PFS (p = 0.009).25